Thyroid nodule screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}} ; {{AE}} {{MIR}} | {{CMG}} ; {{AE}} {{MIR}} | ||
==Overview== | ==Overview== | ||
According to USPSTF, screening for thyroid cancer is not recommended and there is insufficient evidence to recommend routine screening for thyroid nodule. | |||
==Screening== | ==Screening== | ||
According to USPSTF, screening for thyroid cancer is not recommended. | |||
According to the USPSTF, there is insufficient evidence to recommend routine screening for thyroid nodule. | |||
==References== | ==References== | ||
Revision as of 12:41, 15 August 2017
|
Thyroid nodule Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Thyroid nodule screening On the Web |
|
American Roentgen Ray Society Images of Thyroid nodule screening |
|
Risk calculators and risk factors for Thyroid nodule screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Mahshid Mir, M.D. [2]
Overview
According to USPSTF, screening for thyroid cancer is not recommended and there is insufficient evidence to recommend routine screening for thyroid nodule.
Screening
According to USPSTF, screening for thyroid cancer is not recommended. According to the USPSTF, there is insufficient evidence to recommend routine screening for thyroid nodule.